Aerosolized Antibiotics for Treatment of Pneumonia in Mechanically Ventilated Subjects

Fatima J Wong1, Tina Dudney1, Rajiv Dhand2

  • 1Division of Pulmonary and Critical Care Medicine, Department of Medicine, Graduate School of Medicine, University of Tennessee Health Sciences Center Knoxville, Knoxville, Tennessee.

Respiratory Care
|July 27, 2019
PubMed

Insights

Aerosolized antibiotics are being explored to treat ventilator-associated pneumonia (VAP) due to low systemic antibiotic success rates. However, their effectiveness and optimal use remain uncertain, requiring further research.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Pulmonology

Background:

  • Ventilator-associated pneumonia (VAP) is a common and costly complication in mechanically ventilated patients.
  • Current systemic antibiotic treatments for VAP have a success rate below 70%, prompting the search for alternative therapies.
  • Increased mortality, prolonged ICU stays, and higher medical costs are associated with VAP.

Purpose of the Study:

  • To evaluate the potential of aerosolized antibiotics as a treatment modality for VAP.
  • To explore the use of aerosolized antibiotics as monotherapy or adjunct therapy to systemic antibiotics.
  • To identify optimal formulations, dosages, and treatment regimens for aerosolized antibiotic therapy in VAP.

Main Methods:

  • Review of existing clinical data and research on aerosolized antibiotic use in VAP.
  • Analysis of potential benefits and drawbacks of aerosolized antibiotic administration.
  • Identification of knowledge gaps and areas for future investigation.

Main Results:

  • Aerosolized antibiotics show promise but have not consistently improved clinical outcomes in VAP.
  • Potential applications include prevention, monotherapy, adjunctive therapy, and treatment of drug-resistant pathogens.
  • Local and systemic side effects can complicate the use of aerosolized antibiotics.

Conclusions:

  • Further research is needed to establish the efficacy and safety of aerosolized antibiotics for VAP.
  • Optimal dosing, formulations, and treatment strategies require further investigation.
  • Aerosolized antibiotics may offer a valuable therapeutic option for VAP, particularly for drug-resistant infections.

Related Concept Videos

Mechanical Ventilation II: Invasive Ventilation01:23

Mechanical Ventilation II: Invasive Ventilation

Ventilators are essential medical equipment used to aid patients with respiratory difficulties. Their primary function is to assist or replace spontaneous breathing by providing mechanical ventilation. There are two general classes of mechanical ventilators: negative-pressure and positive-pressure ventilators.
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
657
Mechanical Ventilation III: Noninvasive Ventilation01:23

Mechanical Ventilation III: Noninvasive Ventilation

Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation...
536
Mechanical Ventilation I: Indication and Settings01:29

Mechanical Ventilation I: Indication and Settings

Mechanical ventilation is a life-saving technique for managing acute respiratory failure and other respiratory complications. The process involves using a machine known as a ventilator to supply oxygen to the lungs and assist in removing carbon dioxide. It serves as a bridge to long-term mechanical ventilation or a temporary measure until ventilatory support is discontinued. The ventilator can maintain this function for a prolonged period, providing critical support for patients until they can...
2.7K
Antibiotic Selection00:57

Antibiotic Selection

Overview
59.5K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
772
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.7K